NCT00251238View on ClinicalTrials.gov

Efficacy and Tolerability of Ginkgo Biloba Extract in Patients With Raynaud´s Phenomenon

PHASE2CompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

March 31, 2006

Study Completion Date

April 30, 2006

Conditions
Raynaud Disease
Interventions
DRUG

Ginkgo biloba extract EGb 761

daily Ginkgo biloba extract EGb 761

Trial Locations (1)

6525 GH

UMC ST Radboud, Nijmegen

All Listed Sponsors
lead

VSM Geneesmiddelen b.v.

INDUSTRY

NCT00251238 - Efficacy and Tolerability of Ginkgo Biloba Extract in Patients With Raynaud´s Phenomenon | Biotech Hunter | Biotech Hunter